Inserm Unit 901 « MEDITERRANEAN INSTITUTE OF NEUROBIOLOGY (INMED) »
+ 33 (0)6 83 26 11 57
Since 2004, the ‘Tous Chercheurs’ association, presided over by neurobiologist Constance Hammond (Director of Research of Inserm Unit 901 “Mediterranean Institute of Neurobiology (INMED)”), is offering a novel experience to members of patient groups.
This organisation arranges an average of seven practical training courses in biology per year, each one lasting three days, for people affected by chronic diseases (rare genetic diseases, autoimmune diseases, inflammatory diseases, familial cancers, …). The details of this programme have just been published in the journal PloS Biology dated 10 February.
© Tous Chercheurs/M. Mathieu
The groups are composed of 8 to 12 people, members of the same patient group or of groups affected by similar conditions.
Each session takes place at the Tous Chercheurs laboratory, based at the Mediterranean Institute of Neurobiology (INMED, Inserm), on the Luminy Science Campus (University of the Mediterranean).
Each session runs over three periods:
In 10 years, Tous Chercheurs has devised and presented 64 training sessions and as such has trained around 600 members of patient groups.
The prospect for the coming years is to extend this training to other Inserm laboratories. For now, Tous Chercheurs is coordinating training within the French Federation of DNA Schools including four other patient training centres (Angers, Evry-Généthon, Nîmes, Poitiers).
Among the associations welcomed (and associated diseases), we should note AFM (French Muscular Dystrophy Association – neuromuscular diseases), VLM (Cystic Fibrosis), APTEPF (familial polyposis), AFSR (Rett syndrome), AFAF (Friedreich ataxia), ASL (hereditary spastic paraplegia), Wegener (GPA) and other vasculitis updates, AFA (Crohn’s disease and ulcerative colitis), ANDAR (rheumatoid arthritis), AFPCA (relapsing polychondritis), AFDIAG (coeliac disease).
“These three intense, interesting and engaging days have left us “truly wrecked”! We have gone home very contented and only ask for one thing: to go back, revise, go into depth and still with the same aim: understand better to fight back more! Thank you for what you do, thanks for the autoimmune patient groups and thanks for the patients. “
Gilbert – French Association for Relapsing Polychondritis
“A very high level course which aimed at bringing it within reach of everyone and from which the full facts of knowledge, hope and desire to live can be retrieved in order to await achievements in research. “
Michel – Waldenstrom Association France
This was made possible thanks to the support of our funding partners, specifically: AFM-Téléthon, Courtin Arthritis Foundation , the PACA (Provence – Alpes – Côte d’Azur) Region , MENESR (French Ministry of National and Higher Education and Research, the town of Marseille, Inserm and Aix-Marseille University.
Ile-de-France Transport Union (STIF), the public transport authority for the Ile-de-France (Greater Paris) region, and Inserm, the French National Institute of Health and Medical Research, have revealed the results of a study* measuring the physical activity associated with the daily journeys of ...
An international research team involving Inserm and the National Institutes of Health (NIH) has just published the results of the PREVAIL study on treatment for the Ebola virus. While not definitive, the results show that ZMapp may benefit patients with the Ebola ...
“An innovative lab-based training program to help patient groups understand their disease and the research process” Marion Mathieu1, Constance Hammond1,2,3, David G Karlin4
PloS biology, DOI: 10.1371/journal.pbio.1002067
The composition of gut microbiota can predict the efficacy and tolerance of immunotherapy in people with cancer
Drug abuse and depression: towards a new understanding of brain mechanisms
Sickle cell disease : remission of disease symptoms in the world’s first patient treated using gene therapy
Addictive behaviours in adolescents